U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07119463) titled 'Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery' on June 19.

Brief Summary: This study aims to evaluate the impact of goal-oriented albumin infusion on short-term postoperative outcomes in gastric cancer patients. It is a single-center, prospective, non-randomized controlled study. Patients are divided into two groups: the experimental group receives albumin infusion when serum albumin levels fall below 25 g/L, while the control group receives albumin infusion when levels fall below 30 g/L. The primary endpoint is the incidence of complications graded Clavien-Dindo III or a...